Prosecution Insights
Last updated: July 17, 2026
Application No. 18/554,308

CERAMIC MATERIAL, GREEN COMPACT, SINTERED COMPACT, AND ARTICLE

Non-Final OA §102§103
Filed
Oct 06, 2023
Priority
Apr 08, 2021 — JP 2021-065750 +1 more
Examiner
ABU ALI, SHUANGYI
Art Unit
1731
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Tokyo Institute of Technology
OA Round
1 (Non-Final)
45%
Grant Probability
Moderate
1-2
OA Rounds
1y 4m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 45% of resolved cases
45%
Career Allowance Rate
483 granted / 1066 resolved
-19.7% vs TC avg
Strong +38% interview lift
Without
With
+37.9%
Interview Lift
resolved cases with interview
Typical timeline
4y 1m
Avg Prosecution
34 currently pending
Career history
1122
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
77.7%
+37.7% vs TC avg
§102
4.1%
-35.9% vs TC avg
§112
5.5%
-34.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1066 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 1-3 and 8 in the reply filed on 03/23/2026 is acknowledged. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-3 and 8 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over “Electrical properties of La2Mo2O9/Al2O3 nanocomposites fabricated by microwave sintering method” to Zhang et al. Regarding claim 1, Zhang et al. discloses high density nanocrystalline La2Mo2O9 ceramics with addition of alumina. See page2340, left column. Zhang et al. disclose sintered La2Mo2O9 comprising alumina of 1, 2.25, 4.5, 9, and 18 mol%. Table 2 discloses that the Al% is at 2.48% for sintered La2Mo2O9 comprising alumina of 18 mol%. See 2.1. Synthesis; Table 2. Thus, it is reasonable to expect that the 1 mole% alumina is read on the claimed more than 0% by mass and 0.5% or less by mass (2.48/18%) Where the claimed and prior art products are identical or substantially identical in structure or composition, or are produced by identical or substantially identical processes, a prima facie case of either anticipation or obviousness has been established. In re Best, 562 F.2d 1252, 1255, 195 USPQ 430, 433 (CCPA 1977). In the alterative, the reference differs from Applicant's recitations of claims by not disclosing identical ranges. However, the reference discloses "encompassing" ranges, and encompassing ranges have been held to establish prima facie obviousness (MPEP 2144.05). Regarding claim 2, Zhang et al. discloses that all the raw materials (La(NO3)3·6H2O, (NH4)6Mo7O24·4H2O and Al(NO3)3·9H2O) were from Sinopharm Chemical Reagent Co. Ltd., and the purity are higher than 99.0% (AR). For La(NO3)3·6H2O, the major impurities include other rare earth (<0.1%), Ca (<0.02%), Fe (<0.001%), Pb (<0.001%), Cl (<0.001%), SO4 (<0.001%), etc. For (NH4)6Mo7O24·4H2O, the major impurities include SO4 (<0.02%), insoluble matters in water (<0.01%), Pb (<0.001%), Cl (<0.001%), SiO2 (<0.001%), etc. And for Al(NO3)3·9H2O, the major impurities include alkali and earth (<0.2%), insoluble matters in water (<0.01%), SO4 (<0.005%), Fe (<0.002%), Pb (<0.001%), Cl (<0.001%), etc. On all accounts, the impurities are difficult to be examined by experiments due to the too many types and too low concentration. See 2.1. Thus, the ceramic material is free of an element selected from the group consisting of Cd, Hg, Pb, Ra, and U. Regarding claims 3 and 8, Zhang et al. discloses high density nanocrystalline La2Mo2O9 ceramics with addition of alumina. See page 2340, left column. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHUANGYI ABU ALI whose telephone number is (571)272-6453. The examiner can normally be reached Monday - Friday, 8:00 am- 5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Amber Orlando can be reached at (571)270-3149. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHUANGYI ABU ALI/Primary Examiner, Art Unit 1731
Read full office action

Prosecution Timeline

Oct 06, 2023
Application Filed
Jun 23, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679783
Ceramic Reinforced Metal Composite For Hermetic Bodies For Implantable Devices
1y 11m to grant Granted Jul 14, 2026
Patent 12671033
DIELECTRIC COMPOSITION FOR MULTILAYERED CERAMIC CAPACITOR,MULTILAYERED CERAMIC CAPACITOR COMPRISING SAME, AND MANUFACTURING METHOD FOR CAPACITOR
2y 7m to grant Granted Jun 30, 2026
Patent 12653653
METHOD OF PRODUCING BLOCK FOR DENTAL PROSTHESES, AND METHOD OF PRODUCING DENTAL PROSTHESIS
4y 8m to grant Granted Jun 16, 2026
Patent 12643824
BUILDING MATERIALS AND COMPONENTS AND METHODS OF MAKING THE SAME
2y 4m to grant Granted Jun 02, 2026
Patent 12638124
FORMALDEHYDE FREE COMPOSITES MADE WITH CARBOHYDRATE AND ALPHA-CARBON NUCLEOPHILE BINDER COMPOSITIONS
2y 6m to grant Granted May 26, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
45%
Grant Probability
83%
With Interview (+37.9%)
4y 1m (~1y 4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1066 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month